Molecular Biology or Molecular Politics? The Production of Scientific Consensus on the Hazards of Recombinant DNA Technology

Social Studies of Science

Volumn 16, Issue 4, 1986, Pages 593-620

  Wright, Susan ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PUBLIC PARTICIPATION; RECOMBINANT DNA;

ADVISORY COMMITTEE; ARTICLE; BIOMEDICAL AND BEHAVIORAL RESEARCH; CONSUMER; CONTAINMENT; DANGEROUS GOODS; DECISION MAKING; ECOLOGY; GOVERNMENT REGULATION; HAZARDOUS WASTE; HEALTH CARE ORGANIZATION; HEALTH HAZARDS; INTERNATIONAL ASPECTS; INTERNATIONAL COOPERATION; MICROBIOLOGY; NATIONAL INSTITUTES OF HEALTH; NIH GUIDELINES; PERSONNEL; POLICY; RECOMBINANT DNA RESEARCH; SCIENCE; SOCIAL CONTROL; UNITED STATES;

BIOMEDICAL AND BEHAVIORAL RESEARCH; CONTAINMENT; GOVERNMENT REGULATION; HEALTH HAZARDS; INTERNATIONAL ASPECTS; NATIONAL INSTITUTES OF HEALTH; NIH GUIDELINES; PUBLIC PARTICIPATION; RECOMBINANT DNA RESEARCH; SOCIAL CONTROL; UNITED STATES;

ADVISORY COMMITTEES; CONSUMER PARTICIPATION; CONTAINMENT OF BIOHAZARDS; DECISION MAKING; DNA, RECOMBINANT; ECOLOGY; HAZARDOUS SUBSTANCES; INTERNATIONAL COOPERATION; MICROBIOLOGY; NATIONAL INSTITUTES OF HEALTH (U.S.); PUBLIC POLICY; RESEARCH PERSONNEL; SCIENCE; SOCIAL CONTROL, FORMAL; SOCIAL CONTROL, INFORMAL; UNITED STATES;

EID: 0022803485     PISSN: 03063127     EISSN: 14603659     Source Type: Journal    
DOI: 10.1177/030631286016004003     Document Type: Article

References (52)

1. H.M. Collins(ed.)‘Knowledge and Controversy:Studies in Modern Natural Science’, Special Issue of Socialof Science, vol.11, No. 1(February 1981).
2. US House of Representatives, Committee on Science and Technology, Subcommittee on Science, Research and Technology, Science Policy Implic1ations of DNA Recombinant Molecule Research (Washington, DC: US Government Printing Office, 1978), ix.
3. Sheldon Krimsky, Genetic Alchemy: The Social History of the Recombinant DNA Controversy (Cambridge, Mass.: MIT Press, 1982).
4. S. Rayner, ‘The Rules That Keep Us Equal: The Complexity and Costs of Egalitarian Organization’, in J. Flanagan and S. Rayner (eds), Rules, Decisions, and Inequality (London: Gower, 1987, forthcoming).
5. J. Jelsma and W. A. Smit, in ‘Risks of Recombinant DNA Research: From Uncertainty to Certainty’ (to be published in Impact Assessment Today).
6. Department of Health, Education, and Welfare, National Institutes of Health, ‘Recombinant DNA Research: Revised Guidelines’.
7. Office of the Director, NIH, ‘Background on the Proposed Revisions (9/27/77) of the NIH Guidelines for Research Involving Recombinant DNA Molecules’ (November 1977), 29–34.
8. Science Policy Implications of DNA Recombinant Molecule Research, NIH, note 2, vii.
9. Department of Health, Education, and Welfare, National Institutes of Health, ‘Recombinant DNA Research: Revised Guidelines’, Federal Register, Vol. 43, No. 247 (22 December 1978), 60086–87.
10. H. M. Collins, ‘An Empirical Relativist Programme in the Sociology of Scientific Knowledge’, in K. D. Knorr-Cetina and M. Mulkay (eds), Science Observed: Perspectives on the Social Study of Science (London: Sage Publications, 1982), 95–96.
11. National Institutes of Health, Minutes, Meeting of Recombinant DNA Molecule Program Advisory Committee, 27–28 April 1978, 3 (remarks of NIH Director, Donald Fredrickson).
12. P. Bachrach and M. Baratz, ‘Two Faces of Power’, American Political Science Review, Vol. 56 (1962), 947–52.
13. ‘Decisions and Non-Decisions’, American Political Science Review, Vol. 57 (1963), 632–42.
14. R. Cobb and C. Elder, Participation in American Politics: The Dynamics of Agenda Building (Baltimore, Md: The Johns Hopkins University Press, 1972).
15. F. Frey, ‘Comment: on Issues and Non-Issues in the Study of Power’, American Political Science Review, Vol. 65 (1971), 1081–101.
16. M. Crenson, The Unpolitics of Air Pollutions (Baltimore, Md: The Johns Hopkins University Press, 1971).
17. E. E. Schattschneider, The Semi-Sovereign People: A Realist’s View of Democracy in America (New York: Holt, Rinehart and Winston, 1960).
18. Robert Dahl, A Preface to Democratic Theory (Chicago: The University of Chicago Press, 1957).
19. Dahl, A Preface to Democratic Theory, note 9, 72–73.
20. Schattschneider, A Preface to Democratic Theory note 9, 35.
21. Schattschneider, A Preface to Democratic Theory, 71.
22. Bachrach and Baratz, A Preface to Democratic Theory, note 9, 948.
23. N. Wade, ‘Gene Splicing: Senate Bill Draws Charges of Lysenkoism’, Science, Vol. 197 (22 July 1977), 348–50.
24. B. Culliton, ‘Recombinant DNA Bills Derailed: Congress Still Trying to Pass a Law’, Science, Vol. 199 (20 January 1978), 274–77.
25. D. Dickson, ‘Friends of DNA Fight Back’, Nature, Vol. 272 (20 April 1978), 664–65.
26. Malcolm Martin, 22 November 1983.
27. Krimsky, Nature, note 3, 216.
28. Enteric Bacteria Meeting, 31 August 1976, Transcript, 2, 39–40, 42.
29. Enteric Bacteria Meeting, Transcript, Nature, note 17, 6.
30. National Institutes of Health, Recombinant DNA Advisory Committee, Minutes of Meeting, 13–14 September 1976, 9–10.
31. ‘Risk Assessment of Recombinant DNA Experimentation With Escherichia Coli K12’ (Proceedings of a Workshop Held at Falmouth, Massachusetts, 20–21 June 1977), The Journal of Infectious Diseases, Vol. 137, No. 5 (May 1978), 615–16.
32. H. Williams Smith, ‘Is It Safe to Use Escherichia Coli K12 in Recombinant DNA Experiments?’, The Journal of Infectious Diseases, 655–60.
33. Rolf Freter, ‘Possible Effects of Foreign DNA on Pathogenic Potential and Intestinal Proliferation of Escherichia Coif’, The Journal of Infectious Diseases, 624–29.
34. Samuel B. Formal and Richard B. Hornick, ‘Invasive Escherichia ColV’, The Journal of Infectious Diseases, 641–44.
35. Sansonetti, Copecko and Formal, Infection and Immunity, Vol. 34 (1981), 75.
36. E. S. Anderson, ‘Plasmid Transfer in Escherichia Coif’, The Journal of Infectious Diseases, Vol. 137, No. 5 (May 1978), 686–87.
37. Bruce Levin to Donald Fredrickson, 29 July 1977.
38. Jonathan King, ‘Recombinant DNA and Autoimmune Disease’, The Journal of Infectious Diseases, Vol. 137, No. 5 (May 1978), 663–66.
39. ‘Risk Assessment Protocols for Recombinant DNA Experimentation’, The Journal of Infectious Diseases, 704a–08.
40. Sherwood Gorbach to Donald Fredrickson, 14 July 1977.
41. Sydney Brenner, 6 May 1980.
42. Paul Berg to Donald Fredrickson, 13 October 1977: in Department of Health, Education and Welfare, National Institutes of Health, Recombinant DNA Research, Vol. III (September 1978) (Washington, DC: US Government Printing Office, 1978), Appendix A, 12–14.
43. John Tooze, Testimony, Meeting of the Advisory Committee to the Director, NIH on the Proposed Revision of the NIH Guidelines on Recombinant DNA Research, 15–16 December 1977, Transcript, The Journal of Infectious Diseases, 306, 351.
44. Robin Weiss, 18 June 1979.
45. Federal Register, Vol. 43, No. 63 (31 March 1978), 13749.
46. Victor Cohn, ‘Scientists Now Downplay Risks of Genetic Research’, Washington Post (18 July 1977).
47. New York Times (24 July 1977).
48. Peter R. Day, ‘Kennedy Bill Unchanged by Scientists’ ‘Visit’, BioScience, Vol. 27, No. 9 (October 1977), 594.
49. US Senate, Committee on Commerce, Science and Transportation, Subcommittee on Science, Technology and Space, Regulation of Recombinant DNA Research (2, 8 & 10 November 1977), 13, 37, 161.
50. Philip Abelson, ‘Recombinant DNA,’ Science, Vol. 197 (19 August 1977), 721.
51. Herbert Boyer and S. Nicosia (eds), Genetic Engineering (Proceedings of the International Symposium on Genetic Engineering: Scientific Developments and Practical Applications, Milan, 29–31 March 1978) (Amsterdam: Elsevier, 1978), 224.
52. Peter Newmark, ‘WHO Looks for Benefits from Genetic Engineering’, Nature, Vol. 272 (20 April 1978), 663–64.